EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Neuronopathic Gaucher disease: Rare in the West, common in the East

Ozlem Goker-Alpan iD, Margarita M Ivanova iD

Journal of Inherited Metabolic Disease · 2024-09 · 47 (5) · 917-934

DOI: 10.1002/jimd.12749 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 20.05.2024. Verfasst von Ozlem Goker-Alpan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Lysosomal and Rare Disorder Research and Treatment Center, Fairfax, Virginia, USA. Hauptthemen laut MEDLINE: Gaucher Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gaucher disease (GD) stands as one of the most prevalent lysosomal disorders, yet neuronopathic GD (nGD) is an uncommon subset characterized by a wide array of clinical manifestations that complicate diagnosis, particularly when neurological symptoms are understated. nGD may manifest as the acute neuronopathic type, or GD type 2 (GD2), either prenatally or within the first weeks to months of life, whereas GD type 3 (GD3) symptoms may emerge at any point during childhood or occasionally in adolescence. The clinical presentation encompasses severe systemic involvement to mild visceral disease, often coupled with a spectrum of progressive neurological signs and symptoms such as cognitive impairment, ataxia, seizures, myoclonus, varying degrees of brainstem dysfunction presenting with stridor, apneic episodes, and/or impaired swallowing. This manuscript aims to provide a comprehensive review of the incidence, distinctive presentations, and diverse clinical phenotypes of nGD across various countries and regions. It will explore the natural history of the neurodegenerative process in GD, shedding light on its various manifestations during infancy and childhood, and offer insights into the diagnostic journey, the challenges faced in the clinical management, and current and investigative therapeutic approaches for GD's neurological variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gaucher DiseaseHumansPhenotype

Stichwörter der Autor:innen

GBA1Lyso‐Gb1acid beta‐glucocerebrosidaseepidemiologyneuronopathic Gaucher diseasetreatment

Autor:innen und Institutionen

  • Lysosomal and Rare Disorder Research and Treatment Center, Fairfax, Virginia, USA.

ORCID-Profile: Ozlem Goker-Alpan, Margarita M Ivanova

Zitieren

APA

Goker-Alpan, O., & Ivanova, M. M. (2024). Neuronopathic Gaucher disease: Rare in the West, common in the East. Journal of Inherited Metabolic Disease, 47(5), 917-934. https://doi.org/10.1002/jimd.12749

Vancouver

Goker-Alpan O, Ivanova MM. Neuronopathic Gaucher disease: Rare in the West, common in the East. Journal of Inherited Metabolic Disease. 2024;47(5):917-934. doi:10.1002/jimd.12749

BibTeX
@article{GokerAlpan2024,
  author = {Goker-Alpan, Ozlem and Ivanova, Margarita M},
  title = {Neuronopathic Gaucher disease: Rare in the West, common in the East},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2024},
  volume = {47},
  number = {5},
  pages = {917--934},
  doi = {10.1002/jimd.12749}
}
Kostenlos starten →